ERT2-Cre-ERT2 Lentivirus (CMV Promoter)
| Cat. No. | LVP010156 |
| Name | ERT2-Cre-ERT2 Lentivirus (CMV Promoter) |
| Unit | 3 x 250 µl |
| Description |
ERT2-Cre-ERT2 fusion protein of a tamoxifen-regulated form of Cre recombinase and two estrogen receptor T2 (ERT2) genes. Cre recombinase is a Type I topoisomerase from P1 bacteriophage that catalyzes site-specific recombination of DNA between loxP sites. This ready-to-use lentivirus is part of abm’s Lentiviral Expression System and can be used to overexpress your gene of interest in a wide range of host cells. Lentiviruses have the ability to integrate into the host genome and generate a stable cell line expressing your gene of interest. |
| Titer | 107 IU/mL |
| Storage Condition | -80°C |
| Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. LVP010156 |
Print/Download Datasheet
Search CoA here
Other
There are no FAQs for this product yet!
- Yu, S., Li, Y., Ren, H., Zhou, H., Ning, Q., Chen, X., Hu, T., & Yang, L. (2020). PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1. Cancer Chemotherapy and Pharmacology, 87(2), 207–215. https://doi.org/10.1007/s00280-020-04188-9
This product has no review yet.